Anuncia Medical honored as participant in the 2022 Flinn Foundation Bioscience Entrepreneurship Program
SCOTTSDALE, Ariz., March 30, 2022 /PRNewswire/ -- Anuncia Medical, Inc., a medtech startup developing neurotherapeutic devices for treatment of hydrocephalus and other neurological disorders, has been selected as one of seven Arizona early-stage bioscience companies to participate in the 2022 Flinn Foundation Bioscience Entrepreneurship Program. A total of 54 Arizona bioscience firms have been selected for this highly competitive program since 2014 and awarded almost $1.6 million in non-dilutive funding.